Related Experiment Video

Updated: Aug 22, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

MDR1, chemotherapy and chromatin remodeling

Emma K Baker1, Assam El-Osta

  • 1Epigenetics in Human Health and Disease Laboratory, Baker Heart Research Institute, Alfred Medical Research and Education Precinct (AMREP), Prahran, Victoria, Australia.

Cancer Biology & Therapy
|August 25, 2004
PubMed

Insights

Multidrug resistance (MDR) in cancer, driven by P-glycoprotein (Pgp) via MDR1 gene expression, poses a treatment challenge. Epigenetic modifications, including chromatin accessibility, are increasingly recognized as key regulators of MDR1 expression.

Area of Science:

  • Cancer Biology
  • Molecular Biology
  • Epigenetics

Background:

  • Multidrug resistance (MDR) in cancer significantly reduces chemotherapy effectiveness.
  • P-glycoprotein (Pgp) overexpression, mediated by the MDR1 gene, is a primary mechanism of MDR.
  • The precise mechanisms controlling MDR1 gene transcriptional regulation are not fully understood.

Purpose of the Study:

  • To review current research on the role of epigenetic modifications in MDR1 gene expression.
  • To explore how advancements in epigenetics can inform our understanding of MDR1 regulation.
  • To discuss the implications of epigenetic regulation for overcoming chemotherapy resistance.

Main Methods:

  • Literature review of studies investigating MDR1 gene expression.
  • Analysis of research on chromatin accessibility and epigenetic modifications.
  • Synthesis of findings from epigenetics research relevant to MDR1 regulation.

Main Results:

  • Epigenetic modifications, particularly chromatin accessibility, are implicated in controlling MDR1 expression.
  • These epigenetic factors influence the basal expression state of MDR1 and its response to stimuli.
  • Understanding these mechanisms is crucial for developing strategies to combat MDR.

Conclusions:

  • Epigenetic regulation plays a significant role in MDR1-mediated multidrug resistance.
  • Further research into epigenetic mechanisms can reveal novel therapeutic targets.
  • Targeting epigenetic modifications may offer a way to resensitize cancer cells to chemotherapy.

More Related Videos

Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique09:14

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique

Published on: January 14, 2016

Related Concept Videos

Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...